P Pircher

569 total citations
9 papers, 471 citations indexed

About

P Pircher is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, P Pircher has authored 9 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in P Pircher's work include Drug Transport and Resistance Mechanisms (3 papers), Muscle Physiology and Disorders (3 papers) and Adenosine and Purinergic Signaling (1 paper). P Pircher is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Muscle Physiology and Disorders (3 papers) and Adenosine and Purinergic Signaling (1 paper). P Pircher collaborates with scholars based in United States and Sweden. P Pircher's co-authors include Ira G. Schulman, Stefan Westin, Mary Petrowski, Eric D. Bischoff, Rajendra K. Tangirala, Lars Larsson, Jiali Li, Jiali Li, Paul Foster and Jay Wrobel and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Medicine & Science in Sports & Exercise.

In The Last Decade

P Pircher

9 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Pircher United States 7 264 158 145 90 67 9 471
L. J. Miller United States 12 161 0.6× 180 1.1× 286 2.0× 72 0.8× 46 0.7× 25 627
Emilie Dorchies France 8 259 1.0× 239 1.5× 205 1.4× 200 2.2× 135 2.0× 9 558
Michiyasu Ishizawa Japan 12 110 0.4× 159 1.0× 89 0.6× 61 0.7× 43 0.6× 25 468
Eric D. Labonté United States 13 128 0.5× 283 1.8× 264 1.8× 51 0.6× 95 1.4× 14 678
Tor‐Erik Sand Norway 15 105 0.4× 296 1.9× 188 1.3× 76 0.8× 36 0.5× 19 614
Ingrid Påhlman Sweden 11 152 0.6× 123 0.8× 102 0.7× 81 0.9× 53 0.8× 19 457
Xiaozhou Yao United States 8 188 0.7× 165 1.0× 116 0.8× 84 0.9× 22 0.3× 12 382
S. Rapp Germany 6 76 0.3× 228 1.4× 64 0.4× 57 0.6× 140 2.1× 8 611
Xinzhu Liu China 13 116 0.4× 151 1.0× 66 0.5× 156 1.7× 56 0.8× 37 473
M. Dodson Michael United States 13 85 0.3× 212 1.3× 293 2.0× 94 1.0× 134 2.0× 19 592

Countries citing papers authored by P Pircher

Since Specialization
Citations

This map shows the geographic impact of P Pircher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Pircher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Pircher more than expected).

Fields of papers citing papers by P Pircher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Pircher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Pircher. The network helps show where P Pircher may publish in the future.

Co-authorship network of co-authors of P Pircher

This figure shows the co-authorship network connecting the top 25 collaborators of P Pircher. A scholar is included among the top collaborators of P Pircher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Pircher. P Pircher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Martin, Richard, Tielin Wang, Paige E. Mahaney, et al.. (2009). Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR). Journal of Medicinal Chemistry. 52(4). 904–907. 141 indexed citations
2.
Pircher, P, Patrick Chomez, Feiyang Yu, Björn Vennström, & Lars Larsson. (2004). Aberrant expression of myosin isoforms in skeletal muscles from mice lacking therev-erbAαorphan receptor gene. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 288(2). R482–R490. 37 indexed citations
3.
Li, Jiali, P Pircher, Ira G. Schulman, & Stefan Westin. (2004). Regulation of Complement C3 Expression by the Bile Acid Receptor FXR. Journal of Biological Chemistry. 280(9). 7427–7434. 80 indexed citations
4.
Pircher, P, Patrick Chomez, Björn Vennström, & Lars Larsson. (2004). Expression of myosin isoforms in skeletal muscles in mice lacking the rev-erb Alpha orphan receptor. 482–490. 1 indexed citations
5.
Pircher, P, Mary Petrowski, Rajendra K. Tangirala, et al.. (2003). Farnesoid X Receptor Regulates Bile Acid-Amino Acid Conjugation. Journal of Biological Chemistry. 278(30). 27703–27711. 146 indexed citations
6.
Larsson, Lars, et al.. (2001). Effects of Aging on Regulation of Muscle Contraction at the Motor Unit, Muscle Cell, and Molecular Levels. International Journal of Sport Nutrition and Exercise Metabolism. 11(s1). S28–S43. 35 indexed citations
7.
Marx, James O., William J. Kraemer, P Pircher, et al.. (2001). THE EFFECT OF AGING ON MYOSIN HEAVY CHAIN CONCENTRATION IN SKELETAL MUSCLE OF YOUNG AND OLD MEN. Medicine & Science in Sports & Exercise. 33(5). S187–S187. 11 indexed citations
8.
Larsson, Lars, et al.. (1999). Regulation of human muscle contraction at the cellular and molecular levels. Neurological Sciences. 20(6). 413–422. 15 indexed citations
9.
Samuelsson, Jan, L. Tokics, Per Ljungman, et al.. (1999). Acute quadriplegic myopathy following autologous peripheral blood stem cell transplantation for breast cancer. Bone Marrow Transplantation. 23(8). 835–837. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026